Cargando…
Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
INTRODUCTION: Activated partial thromboplastin time (aPTT) is determined and reported as clotting time in seconds aPTT(s), but it is presumed that reporting results as patient-to-normal clotting time ratio, aPTT(r), could minimize within-laboratory variability. The aim of study was to investigate di...
Autores principales: | Bronić, Ana, Margetić, Sandra, Coen Herak, Desiree, Milić, Marija, Krešić, Branka, Radišić Biljak, Vanja, Leniček Krleža, Jasna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183120/ https://www.ncbi.nlm.nih.gov/pubmed/34140831 http://dx.doi.org/10.11613/BM.2021.020708 |
Ejemplares similares
-
Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer
por: Bronić, Ana, et al.
Publicado: (2019) -
Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine
por: Bronić, Ana, et al.
Publicado: (2017) -
Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019) -
Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack
por: Leniček Krleža, Jasna, et al.
Publicado: (2013) -
An Unusual Etiology for Elevation of Activated Partial Thromboplastin Time (aPTT) in SLE: Acquired Hemophilia and Lupus Anticoagulant
por: Seethala, Srikanth, et al.
Publicado: (2013)